Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study.
暂无分享,去创建一个
R. Foley | A. Collins | C. Herzog | A. Ishani
[1] R. Hubbard,et al. Risk of myocardial infarction and stroke after acute infection or vaccination. , 2004, The New England journal of medicine.
[2] S. Beddhu,et al. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. , 2003, Journal of the American Society of Nephrology : JASN.
[3] S. Yusuf,et al. Multiple Infections and Subsequent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study , 2003, Circulation.
[4] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[5] S. Blankenberg,et al. Impact of Infectious Burden on Progression of Carotid Atherosclerosis , 2002, Stroke.
[6] N. Levin,et al. Serum markers of periodontal disease status and inflammation in hemodialysis patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] Patrick S Romano,et al. Can Administrative Data Be Used to Compare Postoperative Complication Rates Across Hospitals? , 2002, Medical care.
[8] David W. Johnson,et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] J. Tokars,et al. New national surveillance system for hemodialysis-associated infections: initial results. , 2002, American journal of infection control.
[10] W. McClellan,et al. Vascular access and increased risk of death among hemodialysis patients. , 2002, Kidney international.
[11] A. Saxena,et al. Outcome of Dialysis Access-Related Septicemia among Diabetics following Optimized AV-Fistula Placement , 2002, Kidney and Blood Pressure Research.
[12] L. Agodoa,et al. Hospitalizations for bacterial septicemia in patients with end stage renal disease due to diabetes on the renal transplant waiting list. , 2002, JN. Journal of Nephrology (Milano. 1992).
[13] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[14] Jein-Wei Liu,et al. Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality. , 2002, The Journal of hospital infection.
[15] K. Stevenson,et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] G. Oster,et al. Is sepsis accurately coded on hospital bills? , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[17] S. Black,et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. , 2002, The New England journal of medicine.
[18] A. Saxena,et al. THE IMPACT OF NASAL CARRIAGE OF METHICILLIN-RESISTANT AND METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS (MRSA & MSSA) ON VASCULAR ACCESS-RELATED SEPTICEMIA AMONG PATIENTS WITH TYPE-II DIABETES ON DIALYSIS , 2002, Renal failure.
[19] E W Young,et al. Type of vascular access and mortality in U.S. hemodialysis patients. , 2001, Kidney international.
[20] G. Nassar,et al. Infectious complications of the hemodialysis access. , 2001, Kidney international.
[21] J. Tokars,et al. A prospective study of vascular access infections at seven outpatient hemodialysis centers. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] B. Horne,et al. Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death , 2001, Circulation.
[23] B. Di Iorio,et al. Successful Use of Central Venous Catheter as Permanent Hemodialysis Access: 84-Month Follow-Up in Lucania , 2000, Blood Purification.
[24] P. Stenvinkel. Inflammatory and Atherosclerotic Interactions in the Depleted Uremic Patient , 2000, Blood Purification.
[25] B. Jaber,et al. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. , 2000, Kidney international.
[26] M. Rocco,et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. , 2000, Kidney international.
[27] W. Schaffner,et al. Hospital-acquired infections among chronic hemodialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[28] F. Locatelli,et al. Treatment modalities in comparison: when do clinical differences emerge? , 2000, Nephrology, Dialysis and Transplantation.
[29] G. Kaysen,et al. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] A. Quyyumi,et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. , 2000, The American journal of cardiology.
[31] N. Powe,et al. Septicemia in dialysis patients: incidence, risk factors, and prognosis. , 1999, Kidney international.
[32] C. Wanner,et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.
[33] D. Sheikh-Hamad,et al. Silent infection in clotted hemodialysis access grafts. , 1998, Journal of the American Society of Nephrology : JASN.
[34] Seoung Woo Lee,et al. Serum C-Reactive Protein: A Predictor of Mortality in Continuous Ambulatory Peritoneal Dialysis Patients , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[35] I. Raad,et al. Intravascular-catheter-related infections , 1998, The Lancet.
[36] R. Mactier,et al. Long-term vascular access for hemodialysis using silicon dual-lumen catheters with guidewire replacement of catheters for technique salvage. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[37] R. Wolfe,et al. Relationship of dose of hemodialysis and cause-specific mortality. , 1996, Kidney international.
[38] E. Anaissie,et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. , 1993, The Journal of infectious diseases.
[39] M. Cirillo,et al. Vascular access for hemodialysis: the impact on morbidity and mortality. , 2004, Journal of nephrology.
[40] B. Gillespie,et al. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. , 2003, Kidney international.
[41] J. Hux,et al. Hemodialysis infection prevention with polysporin ointment. , 2003, Journal of the American Society of Nephrology : JASN.
[42] S. Blankenberg,et al. Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis , 2002, Circulation.